- Fellowship - Cleveland Clinic Foundation (1992-1994), Epilepsy
- Residency - University of Texas Medical Branch Hospital (1989-1992), Neurology
- Internship - University of Texas Medical Branch Hospital (1988-1989), Transitional Year
- Medical School - UNT Health Science Center Texas College of Osteopathic Medicine (1984-1988)
Jay Harvey, D.O.
- Epilepsy & Seizures
A Fellow of the American Epilepsy Society, Dr. Harvey currently chairs the Professional Advisory Board of the Epilepsy Foundation of Texas.
Dr. Harvey’s research focuses on non-traditional epilepsy therapies, including surgery, laser therapy, medical devices such as vagus nerve stimulators and responsive neurostimulators, and cannabidiol (CBD) oil.
He has served as a principal or co-investigator for more than 70 clinical studies, published a number of journal articles and abstracts, and delivered scores of presentations.
Dr. Harvey is certified by the American Board of Psychiatry and Neurology in adult neurology, with added qualifications in epilepsy and clinical neurophysiology. He also is certified by the American Board of Clinical Neurophysiology and the American Board of Sleep Medicine.
Prior to joining the UT Southwestern faculty in 2017, he spent 20 years in private practice, most recently as a partner with Texas Epilepsy Group.
Dr. Harvey earned his Doctor of Osteopathic Medicine degree at the University of North Texas Health Science Center. He completed his medical training and a neurology residency at the University of Texas Medical Branch in Galveston and then received advanced training in epilepsy, electroencephalography (EEG) and sleep disorders through a fellowship at the Cleveland Clinic.
He is a member of professional organizations that include the American Academy of Neurology, American Epilepsy Society, American Clinical Neurophysiology Society, Texas Medical Association, and Texas Neurological Society.
In 2018, he was named a Super Doctor by Texas Monthly.
Meet Dr. Harvey
Neurologist Specializing in Epilepsy in Dallas
Using sophisticated technologies such as electroencephalography and intracranial monitoring, Dr. Harvey and his colleagues at UT Southwestern Medical Center determine if patients are candidates for surgery, device implantation, or clinical trials of promising non-traditional epilepsy treatments.
Fellowship trained, Dr. Harvey is a board certified epileptologist with 20-plus years of clinical expertise.
Dispelling the Myths
In addition to evaluating and treating patients, Dr. Harvey and his team also try to fight the lingering stigma of epilepsy.
"It wasn't very long ago that epilepsy was considered a psychiatric disorder, so there can still be a lot of misinformation surrounding it," he says.
"We work hard to dispel the myths - such as that people with epilepsy are neurologically damaged or mentally impaired, and that women with the disorder shouldn't get pregnant or breastfeed - because these things simply aren't true.
"Most people with epilepsy are very healthy otherwise," he continues, "yet this condition that affects them for only a few minutes at a time can have a devastating impact on their lives and the way other people see them."
Educating the public and healthcare providers is part of the comprehensive epilepsy program at UTSW. Compassion and availability form the foundation for treating patients.
"I have always valued the relationships I have with the people I care for. In addition to treating them, I really enjoy talking with patients."
- American Epilepsy Society (1992), Professional Epilepsy Society
Emergent Admissions to the Epilepsy Monitoring Unit in the Setting of COVID-19 Pandemic-related, State-mandated Restrictions: Clinical Decision Making and Outcomes.
Zepeda R, Lee Y, Agostini M, Alick Lindstrom S, Dave H, Dieppa M, Ding K, Doyle A, Harvey J, Hays R, Perven G, Podkorytova I, Das RR, The Neurodiagnostic journal 2021 Jun 61 2 95-103
Personalized EEG Feature Selection for Low-Complexity Seizure Monitoring.
Peng G, Nourani M, Harvey J, Dave H, International journal of neural systems 2021 Mar 2150018
"Feature Selection Using F-statistic Values for EEG Signal Anayysis"
Peng G, Nourani M, Harvey J, Dave H 2020 42nd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) 2020 Aug
Feature Selection Using F-statistic Values for EEG Signal Analysis.
Peng G, Nourani M, Harvey J, Dave H, Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2020 07 2020 5963-5966
Emergency department visits and readmissions in patients with psychogenic nonepileptic seizures (PNES) at a safety net hospital.
Ramamurthy S, Steven Brown L, Agostini M, Alick Lindstorm S, Dave H, Dieppa M, Ding K, Doyle A, Hays R, Harvey J, Perven G, Podkorytova I, Zepeda R, Das RR, Epilepsy & behavior : E&B 2021 Aug 122 108225
Non-lesional mesial temporal lobe epilepsy requires bilateral invasive evaluation.
Perven G, Podkorytova I, Ding K, Agostini M, Alick S, Das R, Dave H, Dieppa M, Doyle A, Harvey J, Lega B, Zepeda R, Hays R, Epilepsy & behavior reports 2021 15 100441
Automated seizure detection using limited-channel EEG and non-linear dimension reduction.
Birjandtalab J, Baran Pouyan M, Cogan D, Nourani M, Harvey J, Computers in biology and medicine 2017 03 82 49-58
Detection of generalized tonic-clonic seizures using surface electromyographic monitoring.
Halford JJ, Sperling MR, Nair DR, Dlugos DJ, Tatum WO, Harvey J, French JA, Pollard JR, Faught E, Noe KH, Henry TR, Jetter GM, Lie OV, Morgan LC, Girouard MR, Cardenas DP, Whitmire LE, Cavazos JE, Epilepsia 2017 11 58 11 1861-1869
Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine.
Pazdera L, Sperling MR, Harvey JH, Sam MC, Strom LA, Blum D, Grinnell T, Cheng H Epilepsia 2018 Feb
Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a randomized historical-control phase III study based in North America.
Sperling MR, Harvey J, Grinnell T, Cheng H, Blum D, Epilepsia 2015 Apr 56 4 546-55
Epileptic seizure detection using wristworn biosensors.
Cogan D, Nourani M, Harvey J, Nagaraddi V, Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 2015 2015 5086-9
Influence of titration schedule and maintenance dose on the tolerability of adjunctive eslicarbazepine acetate: An integrated analysis of three randomized placebo-controlled trials.
Krauss G, Biton V, Harvey JH, Elger C, Trinka E, Soares da Silva P, Gama H, Cheng H, Grinnell T, Blum D Epilepsy research 2017 Nov 139 1-8
Cannabis and Epilepsy.
Doyle A, Harvey J, Journal of dual diagnosis 2020 Jan-Mar 16 1 75-82
Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial.
Sperling MR, Abou-Khalil B, Harvey J, Rogin JB, Biraben A, Galimberti CA, Kowacs PA, Hong SB, Cheng H, Blum D, Nunes T, Soares-da-Silva P, Epilepsia 2015 Feb 56 2 244-53
Photosensitive temporal lobe epilepsy.
Benbadis SR, Gerson WA, Harvey JH, Lüders HO Neurology 1996 Jun 46 6 1540-2
A wrist-worn biosensor system for assessment of neurological status.
Cogan D, Pouyan MB, Nourani M, Harvey J, Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 2014 2014 5748-51
Multi-Biosignal Analysis for Epileptic Seizure Monitoring.
Cogan D, Birjandtalab J, Nourani M, Harvey J, Nagaraddi V, International journal of neural systems 2017 Feb 27 1 1650031
- Emergent Admissions to the Epilepsy Monitoring Unit in the Setting of COVID-19 Pandemic-related, State-mandated Restrictions: Clinical Decision Making and Outcomes.
- Epilepsy & Seizures